The Ghana Health Service (GHS) has confirmed 20 new Mpox cases, raising the country’s total to 302 as of July 30, 2025.
This latest update follows the country’s first Mpox-related death, reported on July 22, 2025, alongside 23 new cases that had pushed the tally to 257.
Health officials warn that the virus—also known as Monkeypox—continues to spread primarily through close physical contact with infected individuals, including contact with rashes, bodily fluids, or contaminated items.
In a public advisory, the GHS urged citizens to stay alert, avoid close contact with symptomatic individuals, and report suspected cases to the nearest health facility. Symptoms typically include fever, body aches, and a distinctive rash.
“Protect yourself and others by avoiding close contact with those showing symptoms, and ensure you report any suspected signs,” the statement read.
Although most cases resolve without complications, the recent fatality has heightened concerns, particularly for vulnerable groups such as children, pregnant women, and individuals with pre-existing health conditions.
The GHS emphasised that early detection and isolation remain the most effective strategies for controlling the outbreak. Efforts are underway to trace contacts, enhance regional coordination, and step up public awareness campaigns.
The Service also advised the public to seek updates from verified sources to help curb misinformation and aid containment efforts.
In August last year, the World Health Organisation (WHO) declared Mpox a Public Health Emergency of International Concern due to the emergence of a new variant in Africa.
Currently, more than 13 African countries have reported Mpox cases.
It is the second time in two years that the WHO has issued this alert.
As of last year, over 17,000 suspected cases and 517 deaths were reported on the continent, according to the Africa Centres for Disease Control and Prevention.
The WHO has approved the use of an Mpox vaccine, expected to facilitate “timely and increased access” for those at risk, especially in Africa, where more than 20,000 infections have been reported.
